All Type of News
Dong-A ST completes constructing biologic factory in Indonesia to enter its market
Dong-A ST will speed up the process to enter the rapidly-growing Indonesian market by completing the construction of its biologic manufacturing factory.
Dong-A ST(CEO/Vice President Soo-Hyung Kang) announced on the 6...
Hanmi Pharm applies for U.S. approval new biologic ‘Rolontis’ in 4th quarter
Hanmi Pharm is expected to apply for commercialization approval for a new biologic developed by Hanmi Pharm(CEO Sae-Chang Kwon and Jong-Soo Woo) for the treatment of persistent neutropenia, Rolontis, in the U.S. this ...
MFDS enlarge support for drug approval, assessment and consulting
In order to support Korean pharmaceutical companies to rapidly commercialize products they developed and enter the global market, the government will enlarge the tailored support, such as drug approval, assessment and...
MRs having difficulties in meeting with doctors, bringing huge negative impacts on sales
Beginning this January, the ‘Financial Gain & Expenditure Report’ has started to bring impacts in the industry.
Unlike the expectation that the industry would start to adapt to the enforcement after confusion only in...
KPBMA runs association in emergency with next Chair Jung-Hee Lee and Acting Chairman Won-Il Gal
As Chairman Hee-Mok Won resigned his position, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association decided to temporarily run the association in emergency by Jung-Hee Lee, the next Chair, and Acting Chai...
AstraZeneca Korea appoints President Sang-Pyo Kim as CEO
AstraZeneca Korea(CEO/President Sang-Pyo Kim, http://www.astrazeneca.co.kr) announced appointment of Sang-Pyo Kim, the new president, as the CEO as of 1 February.
Before joining in AstraZeneca Korea, CEO/President Sa...
‘Patient Center Control Center’ will strengthen role of pharmacists
The Korean Pharmaceutical Association(KPA) will stress importance of the function of pharmacists at affairs of patient safety and a role of pharmacies and is planning to create a system to compensate benefits related ...
Celltrion meeting requirements for new IPO, getting closer to KOSPI market
As trying hard to go public in a securities market, Celltrion announced in its official notice on the 5th that the company was informed to meet all the requirements of Article 29 of the KOSPI listing regulations and A...
78 cases of compensation for drug damage relief got paid off last year
The Ministry of Food and Drug Safety has reportedly paid 78 cases of compensation under the drug damage relief system in 2017.
Interesting points were that there were 12 cases of temporary compensation for death and ...
Pharma & Biotech industry expected to grow 17% in 2018
While the world’s economic growth rate is anticipated to rarely change at late 3%, the pharmaceutical & biotechnology industry is expected to largely grow 17% up as a new growing industry.
The Export-Import Bank of K...
